GyorgyParaghMD

Physician

Dr. Paragh is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
Elm and Carlton St
Buffalo, NY 14263
Phone+1 716-845-2300

Fax+1 716-845-7608

Medical College of Wisconsin Affiliated HospitalsResidency, Dermatology, 2011 - 2014
University of Debrecen Medical and Health Science CenterClass of 2003

PubMed

Diagnostic Performance of GPT-4o and Gemini Flash 2.0 in Acne and Rosacea.
Mehdi Boostani, András Bánvölgyi, Mohamad Goldust, Carmen Cantisani, Paweł Pietkiewicz
International Journal of Dermatology. 2025-03-10
3 citations
Novel imaging techniques for tumor margin detection in basal cell carcinoma: a systematic scoping review of FDA and EMA-approved imaging modalities.
Mehdi Boostani, Szabolcs Bozsányi, Mariano Suppa, Carmen Cantisani, Kende Lőrincz
International Journal of Dermatology. 2025-02-01
Dermatofibrosarcoma Protuberans, Version 1.2025, NCCN Clinical Practice Guidelines In Oncology.
Jeremy Bordeaux, Rachel Blitzblau, Sumaira Z Aasi, Murad Alam, Arya Amini
Journal of the National Comprehensive Cancer Network. 2025-01-01

Lectures

Role of Dermatologist in Management of Skin Disease in Solid Organ Transplant Recipients
American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/1/2019

Roswell Park Teams Draw in Millions in Grants Supporting New ResearchJuly 12th, 2021
Roswell Park Experts Use Gene Sequencing to Quantify Risk of Skin Cancer Long Before Damage Is VisibleJanuary 4th, 2021
These Combined Biomarkers Help Identify Melanomas at Low Risk of MetastasisJanuary 5th, 2024

Advancing skin cancer prevention by tackling UV-induced clonogenic mutationsROSWELL PARK CANCER INSTITUTE CORP2021–2026
Advancing skin cancer prevention by tackling UV-induced clonogenic mutationsROSWELL PARK CANCER INSTITUTE CORP2021–2026